Status:
UNKNOWN
Effect of N-Acetylcysteine on Peritoneal Membrane Function in Chronic Peritoneal Dialysis Patients
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
ESRD
Peritoneal Dialysis
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The aim of our study is to investigate the effect of N-acetylcysteine on peritoneal small solute clearance and removal of salt and water in prevalent CAPD patients.
Detailed Description
Cardiovascular disease is the commonest cause of morbidity and mortality in chronic dialysis patients, including those treated with CAPD (Continuous Ambulatory Peritoneal Dialysis) \[1\]. Uncontrolled...
Eligibility Criteria
Inclusion
- The study will include 20 patients with ESRD, treated with chronic peritoneal dialysis .
Exclusion
- Recently started treated with chronic dialysis: less than 3 months.
- Survived recent peritonitis in the last 3 months.
- Patients with acute renal failure
- Currently treated with antioxidants ( NAC, vitamin E ets.)
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00421785
Start Date
February 1 2007
End Date
January 1 2008
Last Update
July 9 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dialyss unit
Ẕerifin, Israel, 70300